These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7488406)

  • 1. Haemopoietic stem cell inhibition: potential for dose intensification.
    Marshall E
    Eur J Cancer; 1995 Sep; 31A(10):1586-91. PubMed ID: 7488406
    [No Abstract]   [Full Text] [Related]  

  • 2. Stem cell proliferation inhibitors.
    Wright EG; Pragnell IB
    Baillieres Clin Haematol; 1992 Jul; 5(3):723-39. PubMed ID: 1457966
    [No Abstract]   [Full Text] [Related]  

  • 3. The stem cell compartment: assays and negative regulators.
    Wright EG; Pragnell IB
    Curr Top Microbiol Immunol; 1992; 177():137-49. PubMed ID: 1638868
    [No Abstract]   [Full Text] [Related]  

  • 4. Macrophage inflammatory protein-1 alpha mediated growth inhibition in a haemopoietic stem cell line is associated with inositol 1,4,5 triphosphate generation.
    Heyworth CM; Pearson MA; Dexter TM; Wark G; Owen-Lynch PJ; Whetton AD
    Growth Factors; 1995; 12(3):165-72. PubMed ID: 8619922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating cancer: the potential role of stem cell inhibitors.
    Graham GJ; Pragnell IB
    Eur J Cancer; 1991; 27(8):952-3. PubMed ID: 1832902
    [No Abstract]   [Full Text] [Related]  

  • 6. Negative regulators of haemopoiesis--current advances.
    Graham GJ; Pragnell IB
    Prog Growth Factor Res; 1990; 2(3):181-92. PubMed ID: 2132955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
    Karlic H; Louda N; Pfeilstöcker M; Keil F; Lohninger A; Pittermann E; Paukovits J
    Stem Cells; 2001; 19(4):321-8. PubMed ID: 11463952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage inflammatory protein-1 alpha enhances growth factor-stimulated phosphatidylcholine metabolism and increases cAMP levels in the human growth factor-dependent cell line M07e, events associated with growth suppression.
    Mantel C; Aronica S; Luo Z; Marshall MS; Kim YJ; Cooper S; Hague N; Broxmeyer HE
    J Immunol; 1995 Mar; 154(5):2342-50. PubMed ID: 7532666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical properties.
    Hunter MG; Bawden L; Brotherton D; Craig S; Cribbes S; Czaplewski LG; Dexter TM; Drummond AH; Gearing AH; Heyworth CM; Lord BI; McCourt M; Varley PG; Wood LM; Edwards RM; Lewis PJ
    Blood; 1995 Dec; 86(12):4400-8. PubMed ID: 8541527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the inhibitory effect of AcSDKP, TNF-alpha, TGF-beta, and MIP-1 alpha on marrow-purified CD34+ progenitors.
    Bonnet D; Lemoine FM; Najman A; Guigon M
    Exp Hematol; 1995 Jun; 23(6):551-6. PubMed ID: 7539383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factors. Growth without inflation.
    Dexter TM; White H
    Nature; 1990 Mar; 344(6265):380-1. PubMed ID: 2320106
    [No Abstract]   [Full Text] [Related]  

  • 12. Transforming growth factor beta: is it a downregulator of stem cell inhibition by macrophage inflammatory protein 1 alpha?
    Maltman J; Pragnell IB; Graham GJ
    J Exp Med; 1993 Sep; 178(3):925-32. PubMed ID: 8394405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelosuppressive effects in vivo of purified recombinant murine macrophage inflammatory protein-1 alpha.
    Maze R; Sherry B; Kwon BS; Cerami A; Broxmeyer HE
    J Immunol; 1992 Aug; 149(3):1004-9. PubMed ID: 1634758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.
    Broxmeyer HE; Sherry B; Cooper S; Lu L; Maze R; Beckmann MP; Cerami A; Ralph P
    J Immunol; 1993 Apr; 150(8 Pt 1):3448-58. PubMed ID: 7682242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of small peptidic inhibitors of murine stem cells on human normal and malignant cells.
    Guigon M; Bonnet D; Césaire R; Lemoine F; Najman A
    Ann N Y Acad Sci; 1991; 628():105-14. PubMed ID: 2069291
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation.
    Graham GJ; Wright EG; Hewick R; Wolpe SD; Wilkie NM; Donaldson D; Lorimore S; Pragnell IB
    Nature; 1990 Mar; 344(6265):442-4. PubMed ID: 2320111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymerization of murine macrophage inflammatory protein 1 alpha inactivates its myelosuppressive effects in vitro: the active form is a monomer.
    Mantel C; Kim YJ; Cooper S; Kwon B; Broxmeyer HE
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2232-6. PubMed ID: 8460127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of haemopoiesis and their potential clinical relevance.
    Parker AN; Pragnell IB
    Blood Rev; 1995 Dec; 9(4):226-33. PubMed ID: 8839398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of haemoregulatory peptides (pEEDCK monomer and dimer) for reduction of cytostatic drug induced haemopoietic damage.
    Paukovits WR; Moser MH; Binder KA; Paukovits JB
    Cancer Treat Rev; 1990 Sep; 17(2-3):347-54. PubMed ID: 2272050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory activity of endogenous MIP-1 alpha in long-term cultures of human marrow.
    Cashman JD; Eaves AC; Wolpe S; Eaves CJ
    Prog Clin Biol Res; 1994; 389():261-8. PubMed ID: 7700910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.